Provider
QP37-24 Update for New-to-Market Medical Drugs: atidarsagene autotemcel, crovalimab, and fidanacogene eleparvovec
Program effective Date: May 08, 2024
Program effective Date: May 08, 2024
Program effective Date: May 08, 2024
Program effective Date: May 08, 2024
Program effective Date: May 08, 2024
Program effective Date: May 08, 2024
Program effective Date: May 08, 2024
Program effective Date: May 01, 2024
Program effective Date: May 01, 2024
Program effective Date: May 01, 2024
Program effective Date: May 01, 2024